Skip to content
Medicare Part D update — Jul 1, 2026: Track changes →
Find My Match
Affiliate disclosure: Some links earn commissions. Editorial standards →
Updated for May 2026

Every 2026 GLP-1, side by side.

Independent reviews of every oral and injection GLP-1 receptor agonist available in 2026, with verified pricing, Medicare GLP-1 Bridge coverage, and food-restriction status.

Oral GLP-1s (5)

Foundayo (orforglipron)

No food restrictions Editor's Pick

Oral GLP-1 · Once daily

Avg loss
12–16%
Self-pay from
$149/mo
Plans
42
No food OR water

Rybelsus (semaglutide (oral))

Oral GLP-1 · Once daily

Avg loss
8–10%
Self-pay from
$998/mo
Plans
78
30-min fast required

Wegovy Tablets (semaglutide HD-oral)

Editor's Pick

Oral GLP-1 · Once daily

Avg loss
12–15%
Self-pay from
$149/mo
Plans
31
Empty stomach

Qsymia (phentermine + topiramate ER)

No food restrictions

Oral GLP-1 · Once daily

Avg loss
7–11%
Self-pay from
$230/mo
Plans
28
Take in the morning (avoid evening)

Contrave (naltrexone HCl + bupropion HCl ER)

Oral GLP-1 · Once daily

Avg loss
5–9%
Self-pay from
$650/mo
Plans
35
Avoid high-fat meals

Injection GLP-1s (4)

Included for context — when an oral pill won't deliver enough weight loss for your goal.

Mounjaro (tirzepatide (T2D injection))

No food restrictions

Oral GLP-1 · weekly

Avg loss
12–16%
Self-pay from
$1069/mo
Plans
92
No food restriction

Zepbound (tirzepatide (injection))

No food restrictions

Oral GLP-1 · weekly

Avg loss
18–22%
Self-pay from
$299/mo
Plans
60
No food restriction

Ozempic (semaglutide (T2D injection))

No food restrictions

Oral GLP-1 · weekly

Avg loss
5–8%
Self-pay from
$998/mo
Plans
95
No food restriction

Saxenda (liraglutide (daily injection))

No food restrictions

Oral GLP-1 · Once daily

Avg loss
5–8%
Self-pay from
$1349/mo
Plans
22
No food restriction